» Articles » PMID: 33060323

The Prevalence of Rheumatoid Arthritis: A Systematic Review of Population-based Studies

Overview
Journal J Rheumatol
Specialty Rheumatology
Date 2020 Oct 16
PMID 33060323
Citations 68
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To estimate the prevalence of rheumatoid arthritis (RA) from international population-based studies and investigate the influence of prevalence definition, data sources, classification criteria, and geographical area on RA prevalence.

Methods: A search of ProQuest, MEDLINE, Web of Science, and EMBASE was undertaken to identify population-based studies investigating RA prevalence between 1980 and 2019. Studies were reviewed using the Joanna Briggs Institute approach for the systematic review and Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.

Results: Sixty studies met the inclusion criteria. There was a wide range of point prevalence reported (0.00-2.70%) with a mean of 0.56% (SD 0.51) between 1986 and 2014, and a mean period prevalence of 0.51% (SD 0.35) between 1955 and 2015. RA point and period prevalence was higher in urban settings (0.69% vs 0.48%) than in rural settings (0.54% vs 0.25%). An RA diagnosis validated by rheumatologists yielded the highest period prevalence of RA and was observed in linked databases (0.80%, SD 0.1).

Conclusion: The literature reports a wide range of point and period prevalence based on population and method of data collection, but average point and period prevalence of RA were 51 in 10,000 and 56 in 10,000, respectively. Higher urban vs rural prevalence may be biased due to poor case findings in areas with less healthcare or differences in risk environment. The population database studies were more consistent than sampling studies, and linked databases in different continents appeared to provide a consistent estimate of RA period prevalence, confirming the high value of rheumatologist diagnosis as classification criteria.

Citing Articles

Burden of rheumatoid arthritis in India from 1990 to 2021: insights from the Global Burden of Disease Database.

Shi W, Liang X, Zhang H, Li H Front Med (Lausanne). 2025; 12:1526218.

PMID: 40027898 PMC: 11868046. DOI: 10.3389/fmed.2025.1526218.


Medication Adherence and Illness Perception in Patients with Rheumatoid Arthritis: The Mediating Effect of Self-Efficacy.

Huang L, Zhou Y, Liu Y, Xu P, Deng X J Musculoskelet Neuronal Interact. 2025; 25(1):101-108.

PMID: 40024233 PMC: 11880852. DOI: 10.22540/JMNI-25-101.


New bitongling regulates gut microbiota to predict angiogenesis in rheumatoid arthritis via the gut-joint axis: a deep neural network approach.

Guan Y, Zhao X, Lu Y, Zhang Y, Lu Y, Wang Y Front Microbiol. 2025; 16:1528865.

PMID: 39963498 PMC: 11830818. DOI: 10.3389/fmicb.2025.1528865.


Rheumatoid arthritis and subsequent fracture risk: an individual person meta-analysis to update FRAX.

Kanis J, Johansson H, McCloskey E, Liu E, Schini M, Vandenput L Osteoporos Int. 2025; .

PMID: 39955689 DOI: 10.1007/s00198-025-07397-1.


Review of mesenchymal stem cell-derived exosomes and their potential therapeutic roles in treating rheumatoid arthritis.

Aghajani S, Maboudi S, Seyhoun I, Nia R, Shabestari A, Sharif S Mol Biol Rep. 2025; 52(1):229.

PMID: 39948229 DOI: 10.1007/s11033-025-10290-z.